Manufacturing site
The most modern hyaluronic acid filling-line in the world
The demand for Croma products has led to the construction of a new fully automated manufacturing site which was opened in 2018.
Innovative crosslinking technology
Intensive research and development combined with decades of process optimization led to the proprietary macro (matrix crosslinking) technology for processing hyaluronic acid.
Automation – Stability
Up to 5,000 syringes per hour
Croma always relies on tailor-made production lines, which are characterized by their high level of automation. This unique process control system thus minimizes human influence while guaranteeing consistently high quality and stability.
In addition, all production data are recorded and can be analyzed in detail. During filling with the open RABS system, a technology for aseptic filling is used in addition to terminal sterilization.
“In order to guarantee the best quality and safety in the long term, we have invested promptly and continuously in fully automated production processes. In this segment, that is not a matter of course, but an exception. It is exactly what distinguishes us from our competitors.“
–
Martin Prinz, CTO
Innovative crosslinking technology
Intensive research and development combined with decades of process optimization led to the proprietary macro (matrix crosslinking) technology for processing hyaluronic acid to reach stable and long-lasting HA fillers.
Innovative crosslinking technology
Intensive research and development combined with decades of process optimization led to the proprietary macro (matrix crosslinking) technology for processing hyaluronic acid to reach stable and long-lasting HA fillers.
Automation – Stability – Safety
Up to 5,000 syringes per hour
Croma always relies on tailor-made production lines, which are characterized by their high level of automation. This unique process control system thus minimizes human influence while guaranteeing consistently high quality, stability, and, as a result, safety.
In addition, all production data are recorded and can be analyzed in detail. During filling with the open RABS system, a technology for aseptic filling is used in addition to terminal sterilization.
“In order to guarantee the best quality and safety in the long term, we have invested promptly and continuously in fully automated production processes. In this segment, that is not a matter of course, but an exception. It is exactly what distinguishes us from our competitors.“
–
Martin Prinz, CTO